ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1730

Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis Patients

Rachel AUDO1, Jérome Thireau2, Louis Rauzier3, Marie Barozet1, JACQUES MOREL4, Patrice Bideaux3, alain Lacampagne2 and Claire Daien5, 1CHU Montpellier, Montpellier, France, 2PhyMedExp INSERM U1046, Montpellier, France, 3PhyMedExp U1046, Montpellier, France, 4Protocole thérapeutique immuno-rhumatologie, Montpellier, France, 5University Hospital, Montpellier, France

Meeting: ACR Convergence 2023

Keywords: Brain, Cardiovascular, microbiome, Mouse Models, Other, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1713–1733) RA – Animal Models Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is associated with a high risk of cardiovascular (CV) risks, including accelerated atherosclerosis, left ventricular hypertrophy and decreased heart rate variability (HRV). HRV decrease reflects the inability of the autonomic nervous system (ANS) to adapt cardiac function and lower HRV is associated with a higher risk of CV events. Autonomic dysfunction is observed in RA with a prevalence as high as 60–80% and precedes apparition of symptoms. Given that gut microbiota (GM) dysbiosis also occurs before disease and inflammation in subjects who will develop RA, and that activity of vagus nerve can be modulated by the GM, we hypothesized that GM impairs the ANS balance in RA.

Methods: we investigated whether fecal microbiota transplantation (FMT) of RA patients modulates the electrocardiographic profile, the HRV and cardiac function (echocardiography) compared to FMT of healthy subjects (age-and-sex-matched controls). Using electrocardiogram (ECG) acquired by telemetry, we characterized the impact of FMT on sympathetic and/or vagal outflow using temporal- and spectral-domain analyses of HRV. High resolution echocardiography allowed us to assess both cardiac structural and contractile function. In parallel, FMT consequences on intestinal barrier permeability, the pro- or anti-inflammatory immune cells and early markers of atherosclerosis were evaluated to related potential modification to inflammatory profile.

Results: Heart Rate Variability (HRV) analysis showed that FMT from RA patients altered the ANS activity in mice, reproducing a defect of vagal tone. Indeed, in mice with fecal transfer of RA microbiota (RA-FMT), we observed an increase of heart rate, only during resting time (444.82(±20.07) bpm vs 477.12(±30), p=0.0001, n=34/group). This tachycardia results from a reduction of HRV reflecting altered ANS activity with a decrease in SDNN index (SDNN 23.88±9.97 vs 10.22±4.05 ms, p< 0.0001, n=34/group). Time domain and spectral domain analyses of HRV confirmed a decrease in the parasympathetic activity resulting in a drop of sympathovagal balance. These alterations are independent of cardiac structural, of contractile modifications and of any remodeling of cardiac muscarinic or adrenergic signaling pathway. In addition, this vagal tone dysfunction was independent of inflammation as RA FMT did not induce major immune dysfunction or change in the aortic expression of early markers of atherosclerosis (VCAM and ICAM).

Conclusion: We demonstrated that for the first time that the MI of RA patients contributes to autonomic dysfunction, independently of the inflammatory status, and without structural or contractile modification of the heart. This opens new therapeutic perspectives, such as dietary modifications, for example with the addition of fibre or the use of probiotics, to prevent autonomic dysfunction and CV risk in RA.


Disclosures: R. AUDO: None; J. Thireau: None; L. Rauzier: None; M. Barozet: None; J. MOREL: None; P. Bideaux: None; a. Lacampagne: None; C. Daien: None.

To cite this abstract in AMA style:

AUDO R, Thireau J, Rauzier L, Barozet M, MOREL J, Bideaux P, Lacampagne a, Daien C. Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/gut-microbiota-dysbiosis-impact-autonomic-function-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbiota-dysbiosis-impact-autonomic-function-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology